 |
 |

Inspiring Panic
Arch Gen Psychiatry. 2001;58:123-124.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
THE HISTORY of the investigation of the neurobiology of panic disorder
is largely the history of the pharmacologic challenge paradigm. Beginning
with the 1968 report of Pitts1 that sodium
lactate could provoke panic attacks, the physiologic and psychologic effects
of lactate infusion in patients with panic disorder were intensively investigated
for the next 2 decades. Interest in noradrenergic agents such as yohimbine
and isoproterenol began in the 1980s along with caffeine and carbon dioxide
(CO2). In the last decade, interest in these disparate panicogenic
challenge paradigms has gradually converged on the CO2 inhalation
procedure,2 largely because of its ease and
brevity of administration in conjunction with the known physiology of this
manipulation.
In the study by Battaglia et al,3 the
authors demonstrate that a centrally active muscarinic antagonist (biperiden)
can block induction of panic with CO2, compared with both placebo
and a peripheral cholinergic antagonist. This finding is . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Response Differences of Spontaneous Panic and Fear
Klein
Arch Gen Psychiatry 2002;59:567-569.
FULL TEXT
|